163
Views
5
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD

ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1193-1201 | Published online: 30 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ville A Vartiainen, Federico Lavorini, Anna C Murphy & Klaus F Rabe. (2023) High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD. Expert Opinion on Drug Delivery 20:3, pages 385-393.
Read now
Jill A Ohar, Gary T Ferguson, Donald A Mahler, M Bradley Drummond, Rajiv Dhand, Roy A Pleasants, Antonio Anzueto, David M G Halpin, David B Price, Gail S Drescher, Haley M Hoy, John Haughney, Michael W Hess & Omar S Usmani. (2022) Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 79-92.
Read now

Articles from other publishers (3)

Taye Mekonnen, Xinyu Cai, Christopher Burchell, Hanieh Gholizadeh & Shaokoon Cheng. (2022) A review of upper airway physiology relevant to the delivery and deposition of inhalation aerosols. Advanced Drug Delivery Reviews 191, pages 114530.
Crossref
Sayeed Mossadeq, Rajen Shah, Viraj Shah & Milind Bagul. (2022) Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs. AAPS PharmSciTech 24:1.
Crossref
Federico Lavorini, Jerzy Chudek, Gabriella Gálffy, Abel Pallarés-Sanmartin, Anna S. Pelkonen, Paula Rytilä, Jörgen Syk, Maria Szilasi, Lilla Tamási, Athanasios Xanthopoulos & Tari Haahtela. (2021) Switching to the Dry-Powder Inhaler Easyhaler®: A Narrative Review of the Evidence. Pulmonary Therapy 7:2, pages 409-427.
Crossref